These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 32487847)
1. cGMP Signaling in Cardiovascular Diseases: Linking Genotype and Phenotype. Dang TA; Schunkert H; Kessler T J Cardiovasc Pharmacol; 2020 Jun; 75(6):516-525. PubMed ID: 32487847 [TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in the NO-cGMP pathway and cardiovascular risk. Wobst J; Schunkert H; Kessler T Nitric Oxide; 2018 Jun; 76():105-112. PubMed ID: 29601927 [TBL] [Abstract][Full Text] [Related]
3. Multiplicity of Nitric Oxide and Natriuretic Peptide Signaling in Heart Failure. Preedy MEJ; Baliga RS; Hobbs AJ J Cardiovasc Pharmacol; 2020 May; 75(5):370-384. PubMed ID: 31498237 [TBL] [Abstract][Full Text] [Related]
4. IRAG and novel PKG targeting in the cardiovascular system. Schlossmann J; Desch M Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H672-82. PubMed ID: 21666108 [TBL] [Abstract][Full Text] [Related]
5. [Nitric Oxide Signaling Pathway and Vascular Activity]. Gao YS Sheng Li Ke Xue Jin Zhan; 2017 Feb; 48(1):58-62. PubMed ID: 29927223 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases. Sadek MS; Cachorro E; El-Armouche A; Kämmerer S Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050419 [TBL] [Abstract][Full Text] [Related]
7. Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology. Sun HJ; Wu ZY; Cao L; Zhu MY; Nie XW; Huang DJ; Sun MT; Bian JS Pharmacol Res; 2020 Sep; 159():104961. PubMed ID: 32474086 [TBL] [Abstract][Full Text] [Related]
10. Vascular system: role of nitric oxide in cardiovascular diseases. Bian K; Doursout MF; Murad F J Clin Hypertens (Greenwich); 2008 Apr; 10(4):304-10. PubMed ID: 18401228 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular cGMP-generating systems in physiological and pathological conditions. Cerra MC; Pellegrino D Curr Med Chem; 2007; 14(5):585-99. PubMed ID: 17346149 [TBL] [Abstract][Full Text] [Related]
12. Novel Insights Regarding Nitric Oxide and Cardiovascular Diseases. Infante T; Costa D; Napoli C Angiology; 2021 May; 72(5):411-425. PubMed ID: 33478246 [TBL] [Abstract][Full Text] [Related]
13. Vasorelaxant Effect of a New Hydrogen Sulfide-Nitric Oxide Conjugated Donor in Isolated Rat Aortic Rings through cGMP Pathway. Wu D; Hu Q; Ma F; Zhu YZ Oxid Med Cell Longev; 2016; 2016():7075682. PubMed ID: 26635911 [TBL] [Abstract][Full Text] [Related]
14. Conventional and Unconventional Mechanisms for Soluble Guanylyl Cyclase Signaling. Gao Y J Cardiovasc Pharmacol; 2016 May; 67(5):367-72. PubMed ID: 26452163 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and downstream second messenger cGMP and cAMP enhance adipogenesis in primary human preadipocytes. Hemmrich K; Gummersbach C; Paul NE; Goy D; Suschek CV; Kröncke KD; Pallua N Cytotherapy; 2010 Jul; 12(4):547-53. PubMed ID: 20370354 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of sphingosine-1-phosphate (S1P). Levkau B Handb Exp Pharmacol; 2013; (216):147-70. PubMed ID: 23563656 [TBL] [Abstract][Full Text] [Related]
17. What is next in nitric oxide research? From cardiovascular system to cancer biology. Bian K; Murad F Nitric Oxide; 2014 Dec; 43():3-7. PubMed ID: 25153032 [TBL] [Abstract][Full Text] [Related]
18. Targets of cGMP/cGKI in Cardiac Myocytes. Adler J; Kuret A; Längst N; Lukowski R J Cardiovasc Pharmacol; 2020 Jun; 75(6):494-507. PubMed ID: 32168155 [TBL] [Abstract][Full Text] [Related]
19. Sildenafil Prevents Apoptosis of Human First-Trimester Trophoblast Cells Exposed to Oxidative Stress: Possible Role for Nitric Oxide Activation of 3',5'-cyclic Guanosine Monophosphate Signaling. Bolnick JM; Kilburn BA; Bolnick AD; Diamond MP; Singh M; Hertz M; Dai J; Armant DR Reprod Sci; 2015 Jun; 22(6):718-24. PubMed ID: 25431453 [TBL] [Abstract][Full Text] [Related]